Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Ibrutinib plus CIT for R/R mature B-NHL in children (SPARKLE trial): initial safety, pharmacokinetics, and efficacy.
Leukemia ( IF 12.8 ) Pub Date : 2020-02-18 , DOI: 10.1038/s41375-020-0749-5 G A Amos Burke 1 , Auke Beishuizen 2 , Deepa Bhojwani 3 , Birgit Burkhardt 4 , Véronique Minard-Colin 5 , Robin E Norris 6 , Edita Kabickova 7 , F Guclu Pinarli 8 , Nurdan Tacyildiz 9 , Angela Howes 10 , Jan de Jong 11 , Grace Liu 12 , Kerri Nottage 12 , Mariya Salman 12 , Xavier Woot de Trixhe 13 , Mitchell Cairo 14
中文翻译：
依鲁替尼联合 CIT 治疗儿童 R/R 成熟 B-NHL（SPARKLE 试验）：初始安全性、药代动力学和疗效。
更新日期：2020-02-19
Leukemia ( IF 12.8 ) Pub Date : 2020-02-18 , DOI: 10.1038/s41375-020-0749-5 G A Amos Burke 1 , Auke Beishuizen 2 , Deepa Bhojwani 3 , Birgit Burkhardt 4 , Véronique Minard-Colin 5 , Robin E Norris 6 , Edita Kabickova 7 , F Guclu Pinarli 8 , Nurdan Tacyildiz 9 , Angela Howes 10 , Jan de Jong 11 , Grace Liu 12 , Kerri Nottage 12 , Mariya Salman 12 , Xavier Woot de Trixhe 13 , Mitchell Cairo 14
Affiliation
|
中文翻译：
依鲁替尼联合 CIT 治疗儿童 R/R 成熟 B-NHL（SPARKLE 试验）：初始安全性、药代动力学和疗效。
京公网安备 11010802027423号